Phase 1 Chronic Pancreatitis Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1
Autologous Mesenchymal Stromal Cells and Islet Co-transplantation in TP-IAT
Chronic PancreatitisMesenchymal Stem Cells
Medical University of South Carolina42 enrolled1 locationNCT05095532
Recruiting
Phase 1
Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis
Chronic PainChronic Pancreatitis
VA Office of Research and Development40 enrolled1 locationNCT05925036
Recruiting
Phase 1
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis
Chronic PainChronic PancreatitisChronic Pain Syndrome+1 more
Indiana University24 enrolled5 locationsNCT05603702
Recruiting
Phase 1Phase 2
Soy Tomato Juice to Improve Outcomes in Pancreatitis
Chronic PancreatitisRecurrent Acute Pancreatitis
Ohio State University35 enrolled1 locationNCT07447687